NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $208,000 | -99.7% | 3 | -99.6% | 0.00% | -100.0% |
Q1 2022 | $65,365,000 | -8.4% | 789 | -16.9% | 0.02% | +5.9% |
Q4 2021 | $71,323,000 | -50.2% | 950 | -23.0% | 0.02% | -50.0% |
Q3 2021 | $143,349,000 | -47.1% | 1,234 | -14.2% | 0.03% | -44.3% |
Q2 2021 | $271,028,000 | +8.5% | 1,438 | -23.9% | 0.06% | -14.1% |
Q1 2021 | $249,811,000 | -46.7% | 1,890 | -30.2% | 0.07% | -48.6% |
Q4 2020 | $468,747,000 | – | 2,709 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |